Disclosures for "COPE: Chain-of-thought Prediction Engine for Open-source Large Language Model Based Stroke Outcome Prediction from Clinical Notes"
-
Dr. Liu has nothing to disclose.
-
Miss Feng has nothing to disclose.
-
Ms. Jiang has nothing to disclose.
-
Dr. Wintermark has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Subtle Medical. Dr. Wintermark has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AJNR.
-
Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
-
Dr. Moseley has nothing to disclose.
-
Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Richard & Connor. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keating Jones Hughes. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chason, Rosner, Leary & Marshall. Dr. Lansberg has received publishing royalties from a publication relating to health care.
-
Author has nothing to disclose
-
Dr. Heit has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Heit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MicroVention. Dr. Heit has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for iSchemaView. Dr. Heit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MicroVention. Dr. Heit has stock in Dragon Vascular.
-
An immediate family member of Prof. Zaharchuk has received personal compensation for serving as an employee of Subtle Medical. Prof. Zaharchuk has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Subtle Medical. Prof. Zaharchuk has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ISMRM. Prof. Zaharchuk has stock in Subtle Medical. The institution of Prof. Zaharchuk has received research support from National Institutes of Health. Prof. Zaharchuk has received intellectual property interests from a discovery or technology relating to health care. Prof. Zaharchuk has received publishing royalties from a publication relating to health care.